AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-79
Results: 51-75/79
Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers
Authors: Tacket, CO Sztein, MB Wasserman, SS Losonsky, G Kotloff, KL Wyant, TL Nataro, JP Edelman, R Perry, J Bedford, P Brown, D Chatfield, S Dougan, G Levine, MM
Citation: Co. Tacket et al., Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD 908-htrA in US volunteers, INFEC IMMUN, 68(3), 2000, pp. 1196-1201
Inhibition of T-cell response by Escherichia coli heat-labile enterotoxin-treated epithelial cells
Authors: Lopes, LM Maroof, A Dougan, G Chain, BM
Citation: Lm. Lopes et al., Inhibition of T-cell response by Escherichia coli heat-labile enterotoxin-treated epithelial cells, INFEC IMMUN, 68(12), 2000, pp. 6891-6895
Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistanceto oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens
Authors: Mastroeni, P Simmons, C Fowler, R Hormaeche, CE Dougan, G
Citation: P. Mastroeni et al., Igh-6(-/-) (B-cell-deficient) mice fail to mount solid acquired resistanceto oral challenge with virulent Salmonella enterica serovar typhimurium and show impaired Th1 T-cell responses to Salmonella antigens, INFEC IMMUN, 68(1), 2000, pp. 46-53
Enterohaemorrhagic Escherichia coli O157 : H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine
Authors: Phillips, AD Navabpour, S Hicks, S Dougan, G Wallis, T Frankel, G
Citation: Ad. Phillips et al., Enterohaemorrhagic Escherichia coli O157 : H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine, GUT, 47(3), 2000, pp. 377-381
The rpoS-dependent starvation-stress response locus stiA encodes a nitratereductase (narZYWV) required for carbon-starvationinducible thermotolerance and acid tolerance in Salmonella typhimurium
Authors: Spector, MP del Portillo, FG Bearson, SMD Mahmud, A Magut, M Finlay, BB Dougan, G Foster, JW Pallen, MJ
Citation: Mp. Spector et al., The rpoS-dependent starvation-stress response locus stiA encodes a nitratereductase (narZYWV) required for carbon-starvationinducible thermotolerance and acid tolerance in Salmonella typhimurium, MICROBIO-UK, 145, 1999, pp. 3035-3045
The medium-/long-chain fatty acyl-CoA dehydrogenase (fadF) gene of Salmonella typhimurium is a phase 1 starvation-stress response (SSR) locus
Authors: Spector, MP DiRusso, CC Pallen, MJ del Portillo, FG Dougan, G Finlay, BB
Citation: Mp. Spector et al., The medium-/long-chain fatty acyl-CoA dehydrogenase (fadF) gene of Salmonella typhimurium is a phase 1 starvation-stress response (SSR) locus, MICROBIO-UK, 145, 1999, pp. 15-31
Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli
Authors: Kelly, G Prasannan, S Daniell, S Fleming, K Frankel, G Dougan, G Connerton, I Matthews, S
Citation: G. Kelly et al., Structure of the cell-adhesion fragment of intimin from enteropathogenic Escherichia coli, NAT ST BIOL, 6(4), 1999, pp. 313-318
Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells
Authors: Hartland, EL Batchelor, M Delahay, RM Hale, C Matthews, S Dougan, G Knutton, S Connerton, I Frankel, G
Citation: El. Hartland et al., Binding of intimin from enteropathogenic Escherichia coli to Tir and to host cells, MOL MICROB, 32(1), 1999, pp. 151-158
Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant
Authors: Petrovska, L Hewinson, RG Dougan, G Maskell, DJ Woodward, MJ
Citation: L. Petrovska et al., Brucella melitensis 16M: characterisation of the galE gene and mouse immunisation studies with a galE deficient mutant, VET MICROB, 65(1), 1999, pp. 21-36
Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region
Authors: Street, M Herd, K Londono, P Doan, T Dougan, G Kast, WM Tindle, RW
Citation: M. Street et al., Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region, ARCH VIROL, 144(7), 1999, pp. 1323-1343
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
Authors: Rappuoli, R Pizza, M Douce, G Dougan, G
Citation: R. Rappuoli et al., Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins, IMMUNOL TOD, 20(11), 1999, pp. 493-500
Ferrioxamine-mediated iron(III) utilization by Salmonella enterica
Authors: Kingsley, RA Reissbrodt, R Rabsch, W Ketley, JM Tsolis, RM Everest, P Dougan, G Baumler, AJ Roberts, M Williams, PH
Citation: Ra. Kingsley et al., Ferrioxamine-mediated iron(III) utilization by Salmonella enterica, APPL ENVIR, 65(4), 1999, pp. 1610-1618
Molecular typing of multiple-antibiotic-resistant Salmonella enterica serovar Typhi from Vietnam: Application to acute and relapse cases of typhoid fever
Authors: Wain, J Hien, TT Connerton, P Ali, T Parry, CM Chinh, NTT Vinh, H Phuong, CXT Ho, VA Diep, TS Farrar, JJ White, NJ Dougan, G
Citation: J. Wain et al., Molecular typing of multiple-antibiotic-resistant Salmonella enterica serovar Typhi from Vietnam: Application to acute and relapse cases of typhoid fever, J CLIN MICR, 37(8), 1999, pp. 2466-2472
Development of a universal intimin antiserum and PCR primers
Authors: Batchelor, M Knutton, S Caprioli, A Huter, V Zanial, M Dougan, G Frankel, G
Citation: M. Batchelor et al., Development of a universal intimin antiserum and PCR primers, J CLIN MICR, 37(12), 1999, pp. 3822-3827
Role of bacterial intimin in colonic hyperplasia and inflammation
Authors: Higgins, LM Frankel, G Connerton, I Goncalves, NS Dougan, G MacDonald, TT
Citation: Lm. Higgins et al., Role of bacterial intimin in colonic hyperplasia and inflammation, SCIENCE, 285(5427), 1999, pp. 588-591
MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
Authors: Simmons, CP Mastroeni, P Fowler, R Ghaem-maghami, M Lycke, N Pizza, M Rappuoli, R Dougan, G
Citation: Cp. Simmons et al., MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants, J IMMUNOL, 163(12), 1999, pp. 6502-6510
Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants
Authors: Douce, G Giannelli, V Pizza, M Lewis, D Everest, P Rappuoli, R Dougan, G
Citation: G. Douce et al., Genetically detoxified mutants of heat-labile toxin from Escherichia coli are able to act as oral adjuvants, INFEC IMMUN, 67(9), 1999, pp. 4400-4406
Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis
Authors: Everest, P Ketley, J Hardy, S Douce, G Khan, S Shea, J Holden, D Maskell, D Dougan, G
Citation: P. Everest et al., Evaluation of Salmonella typhimurium mutants in a model of experimental gastroenteritis, INFEC IMMUN, 67(6), 1999, pp. 2815-2821
Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease
Authors: Higgins, LM Frankel, G Douce, G Dougan, G MacDonald, TT
Citation: Lm. Higgins et al., Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease, INFEC IMMUN, 67(6), 1999, pp. 3031-3039
Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A
Authors: Ward, SJ Douce, G Figueiredo, D Dougan, G Wren, BW
Citation: Sj. Ward et al., Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A, INFEC IMMUN, 67(5), 1999, pp. 2145-2152
Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium
Authors: Mastroeni, P Clare, S Khan, S Harrison, JA Hormaeche, CE Okamura, H Kurimoto, M Dougan, G
Citation: P. Mastroeni et al., Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium, INFEC IMMUN, 67(2), 1999, pp. 478-483
Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA
Authors: Lowe, DC Savidge, TC Pickard, D Eckmann, L Kagnoff, MF Dougan, G Chatfield, SN
Citation: Dc. Lowe et al., Characterization of candidate live oral Salmonella typhi vaccine strains harboring defined mutations in aroA, aroC, and htrA, INFEC IMMUN, 67(2), 1999, pp. 700-707
Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin a from Clostridium difficile
Authors: Ward, SJ Douce, G Dougan, G Wren, BW
Citation: Sj. Ward et al., Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin a from Clostridium difficile, INFEC IMMUN, 67(10), 1999, pp. 5124-5132
Vaccines against gut pathogens
Authors: Mastroeni, P Bowe, F Cahill, R Simmons, C Dougan, G
Citation: P. Mastroeni et al., Vaccines against gut pathogens, GUT, 45(5), 1999, pp. 633-635
Recombinant soluble human CD69 dimer produced in Escherichia coli: Reevaluation of saccharide binding
Authors: Childs, RA Galustian, C Lawson, AM Dougan, G Benwell, K Frankel, C Feizi, T
Citation: Ra. Childs et al., Recombinant soluble human CD69 dimer produced in Escherichia coli: Reevaluation of saccharide binding, BIOC BIOP R, 266(1), 1999, pp. 19-23
Risultati: 1-25 | 26-50 | 51-75 | 76-79